Skip to search.
 TSX Up 0.60% TSX Ventures Up 1.02%

Osiris Therapeutics, Inc. (OSIR)

-NasdaqGM
21.33 Up 0.28(1.33%) Jul 31, 4:00PM EDT
|After Hours : 21.33 0.00 (0.00%) Jul 31, 5:36PM EDT
Add to Portfolio
Prev Close:21.05
Open:21.15
Bid:9.45 x 100
Ask:21.99 x 100
1y Target Est:23.50
Beta:0.04
Next Earnings Date: 5-Aug-15OSIR Earnings announcement
Day's Range:21.05 - 21.69
52wk Range:11.87 - 23.67
Volume:120,571
Avg Vol (3m):167,353
Market Cap:733.54M
P/E (ttm):761.79
EPS (ttm):0.03
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
OSIRUp 1.33%733.54M
ABTDown 0.16%75.47B
BIIBUp 0.56%74.97B

Key Statistics

Forward P/E (1 yr):32.82
P/S (ttm):10.22
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :0.41
Quarterly EPS Est (Jun-15) :0.06
Mean Recommendation*:1.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Osiris Therapeutics, Inc. researches, develops, manufactures, markets, and distributes regenerative medicine products in the United States. Its products include Grafix, a cryopreserved placental membrane for treating hard-to-treat acute and chroni... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback